National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 28674 [2017-13077]
Download as PDF
<![CDATA[
28674
Federal Register / Vol. 82, No. 120 / Friday, June 23, 2017 / Notices
MD 20892, 301–827–5840,
julia.berzhanskaya@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Expanding Medication Assisted Treatment
for Opioid Use Disorders in the Context of
the SAMHSA Opioid STR Grants (R21/R33).
Date: July 25, 2017.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, National Institutes
of Health, DHHS, 6001 Executive Boulevard,
Room 4238, MSC 9550, Bethesda, MD 20892,
301–827–5820, hiromi.ono@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: June 19, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–13078 Filed 6–22–17; 8:45 am]
Contact Person: Zhuqing (Charlie) Li,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, Room #3G41B, National Institutes
of Health/NIAID, 5601 Fishers Lane,
MSC9823, Bethesda, MD 20892–9823, (240)
669–5068, zhuqing.li@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; LIMITED COMPETITION:
CTOT–C MECHANISTIC ANCILLARY
STUDIES (U01).
Date: July 18, 2017.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Zhuqing (Charlie) Li,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, Room #3G41B, National Institutes
of Health/NIAID, 5601 Fishers Lane,
MSC9823, Bethesda, MD 20892–9823, (240)
669–5068, zhuqing.li@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 19, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–13077 Filed 6–22–17; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID CLINICAL TRIAL
PLANNING GRANT (R34).
Date: July 17, 2017.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
VerDate Sep<11>2014
19:21 Jun 22, 2017
Jkt 241001
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–6036–N–01]
Housing Trust Fund Federal Register;
Allocation Notice
Office of the Assistant
Secretary for Community Planning and
Development, HUD.
ACTION: Notice of Fiscal Year 2017
Funding Awards.
AGENCY:
The Housing and Economic
Recovery Act of 2008 (HERA)
established the Housing Trust Fund
(HTF) to be administered by HUD.
Pursuant to the Federal Housing
Enterprises Financial Security and
Soundness Act of 1992 (the Act), as
amended by HERA, Division A, eligible
HTF grantees are the 50 states, the
District of Columbia, the
Commonwealth of Puerto Rico,
American Samoa, Guam, the
Commonwealth of Northern Mariana
Islands, and the United States Virgin
Islands. In accordance with Section
1338(c)(4)(A) of the Act, this notice
announces the formula allocation
amount for each eligible HTF grantee.
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Virginia Sardone, Director, Office of
Affordable Housing Programs, Room
7164, Department of Housing and Urban
Development, 451 Seventh Street SW.,
Washington, DC 20410–7000; telephone
(202) 708–2684. (This is not a toll-free
number.) A telecommunications device
for hearing- and speech-impaired
persons (TTY) is available at 800–877–
8339 (Federal Relay Service).
Section
1131 of HERA Division A amended the
Act to add a new section 1337 entitled
‘‘Affordable Housing Allocations’’ and a
new section 1338 entitled ‘‘Housing
Trust Fund.’’ HUD’s implementing
regulations are codified at 24 CFR part
93. Congress authorized the HTF with
the stated purpose of: (1) Increasing and
preserving the supply of rental housing
for extremely low-income families with
incomes between 0 and 30 percent of
area median income and very lowincome families with incomes between
30 and 50 percent of area median
income, including homeless families,
and (2) increasing homeownership for
extremely low-income and very lowincome families. Section 1337 of the Act
provides for the HTF (and other
programs) to be funded with an
affordable housing set-aside by Fannie
Mae and Freddie Mac. The total setaside amount is equal to 4.2 basis points
(.042 percent) of Fannie Mae and
Freddie Mac’s new mortgage purchases,
a portion of which is for the HTF.
Section 1338 of the Act directs HUD to
establish, through regulation, the
formula for distribution of amounts
made available for the HTF. The statute
specifies the factors to be used for the
formula and priority for certain factors.
The factors and methodology HUD uses
to allocate HTF funds among eligible
grantees are established in the HTF
regulation. The funding announced for
Fiscal Year 2017 through this notice is
$219,168,373.94. This amount includes
$12,702,747 of unobligated Fiscal Year
2016 HTF funds that will be reallocated
by formula, which are comprised of
$37,298 from American Samoa, Guam,
and the Commonwealth of Northern
Mariana Islands, three Insular Areas that
declined their Fiscal Year 2016
allocations and $12,665,449 of
Sequestered Fiscal Year 2016 funds.
HUD may add any amounts that may
become available to these FY 2017 HTF
allocation amounts. Appendix A to this
notice provides the names of the
grantees and the amounts of the awards.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\23JNN1.SGM
23JNN1
]]>Agencies
[Federal Register Volume 82, Number 120 (Friday, June 23, 2017)]
[Notices]
[Page 28674]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13077]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID CLINICAL TRIAL PLANNING GRANT
(R34).
Date: July 17, 2017.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Zhuqing (Charlie) Li, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room #3G41B, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC9823, Bethesda, MD 20892-9823, (240) 669-5068,
zhuqing.li@nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; LIMITED COMPETITION: CTOT-C
MECHANISTIC ANCILLARY STUDIES (U01).
Date: July 18, 2017.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Zhuqing (Charlie) Li, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room #3G41B, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC9823, Bethesda, MD 20892-9823, (240) 669-5068,
zhuqing.li@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: June 19, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-13077 Filed 6-22-17; 8:45 am]
BILLING CODE 4140-01-P
